申请人:Tsukamoto Tetsuya
公开号:US20090156582A1
公开(公告)日:2009-06-18
The present invention provides a pyrazole compound represented by the formula (I):
wherein ring A
0
is a pyrazole ring optionally further having 1 or 2 substituents; R
a
is a substituted carbamoyl group; and R
b
is an optionally substituted acylamino group, or a salt thereof or a prodrug thereof, which is useful as an agent for the prophylaxis or treatment of GSK-3β related pathology or disease, and a GSK-3β inhibitor including same.
本发明提供了一种由以下式(I)表示的吡唑化合物:
其中环A0是一个吡唑环,可选择地进一步具有1或2个取代基;Ra是一个取代的氨基甲酰基团;Rb是一个可选择地取代的酰胺基团,或其盐或前药,用作预防或治疗与GSK-3β相关的病理或疾病的药剂,以及包括其在内的GSK-3β抑制剂。